EVALUATION OF RESPIRATORY MUSCLES` FUNCTION IN PATIENTS AFFECTED BY ALS WITH HEAVY METAL POISONING - EDTA
- Conditions
- PATIENTS AFFECTED BY ALSMedDRA version: 9.1Level: PTClassification code 10002026
- Registration Number
- EUCTR2010-020010-28-IT
- Lead Sponsor
- Dr.ssa Marina Aiello-Universit? degli studi di Parma
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
a.Certained ALS dignosis, probable or probable and laboratory tests supported ALS diagnosis. b.Age > 18 years c.Written informed consent.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
a.Former poliomyelitis b.Other motor neuron disease c.Patients unable to give their written informed consent
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: The aim of this study is to evaluate heavy metal poisoning in patients affected by ALS admitted to our out-patients clinic.;Secondary Objective: To assess the role of heavy metal poisoning in the progression of ALS in order to suggest other therapeutic strategies.;Primary end point(s): The aim of this study is to evaluate heavy metal poisoning in patients affected by ALS admitted to our out-patients clinic.
- Secondary Outcome Measures
Name Time Method